newsfilter
← Latest News
GlobeNewswire·

Allogene Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update

Conference Call and Webcast Scheduled for August 13, 2025 at 2:00 p.m. PT/5:00 p.m. ET SOUTH SAN FRANCISCO, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (NASDAQ:ALLO), a clinical-stage